124 related articles for article (PubMed ID: 17207586)
1. Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers.
Yoo NJ; Lee SH; Jeong EG; Lee JW; Soung YH; Nam SW; Kim SH; Lee JY; Lee SH
Pathol Res Pract; 2007; 203(2):73-8. PubMed ID: 17207586
[TBL] [Abstract][Full Text] [Related]
2. Expression of phosphorylated caspase-9 in gastric carcinomas.
Yoo NJ; Lee SH; Jeong EG; Lee SH
APMIS; 2007 Apr; 115(4):354-9. PubMed ID: 17504303
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation status of Fas-associated death domain-containing protein regulates telomerase activity and strongly correlates with prostate cancer outcomes.
Matsumura Y; Shimada K; Tanaka N; Fujimoto K; Hirao Y; Konishi N
Pathobiology; 2009; 76(6):293-302. PubMed ID: 19955841
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas.
Lee SH; Jeong EG; Nam SW; Lee JY; Yoo NJ; Lee SH
Pathology; 2007 Jun; 39(3):326-9. PubMed ID: 17558859
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas.
Lee JW; Jeong EG; Soung YH; Nam SW; Lee JY; Yoo NJ; Lee SH
Pathology; 2006 Aug; 38(4):312-5. PubMed ID: 16916719
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of apoptosis-inducing factor (AIF) expression in gastric carcinomas.
Lee JW; Jeong EG; Soung YH; Kim SY; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Pathol Res Pract; 2006; 202(7):497-501. PubMed ID: 16723191
[TBL] [Abstract][Full Text] [Related]
8. The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray.
Gomes TS; Oshima CT; Segreto HR; Barrazueta LM; Costa HO; Lima FO; Forones NM; Ribeiro DA
Pathol Res Pract; 2011 Oct; 207(10):613-7. PubMed ID: 21856093
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of Fas and FLIP in prostate cancers.
Kim SY; Song SY; Kim MS; Lee JY; Lee HM; Choi HY; Yoo NJ; Lee SH
APMIS; 2009 Jan; 117(1):28-33. PubMed ID: 19161534
[TBL] [Abstract][Full Text] [Related]
12. [Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis].
Wang LW; Li Q; Hua ZL; Zhou F; Keping X; Daoyan W; Yao J; Ajani J
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):107-11. PubMed ID: 17645844
[TBL] [Abstract][Full Text] [Related]
13. Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers.
Kim SS; Ahn CH; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
Pathology; 2010 Jan; 42(1):50-3. PubMed ID: 20025480
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of the KLF4 in colorectal cancers.
Choi BJ; Cho YG; Song JW; Kim CJ; Kim SY; Nam SW; Yoo NJ; Lee JY; Park WS
Pathol Res Pract; 2006; 202(8):585-9. PubMed ID: 16814484
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma.
Zhu F; Xu C; Jiang Z; Jin M; Wang L; Zeng S; Teng L; Cao J
Anat Rec (Hoboken); 2010 Aug; 293(8):1310-4. PubMed ID: 20665809
[TBL] [Abstract][Full Text] [Related]
16. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
Ishii HH; Gobe GC; Ebihara Y
Hepatogastroenterology; 2007; 54(79):2159-63. PubMed ID: 18251181
[TBL] [Abstract][Full Text] [Related]
17. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
18. Subcellular compartmentalization of FADD as a new level of regulation in death receptor signaling.
Föger N; Bulfone-Paus S; Chan AC; Lee KH
FEBS J; 2009 Aug; 276(15):4256-65. PubMed ID: 19583773
[TBL] [Abstract][Full Text] [Related]
19. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
20. Mutational and expressional analysis of BNIP3, a pro-apoptotic Bcl-2 member, in gastric carcinomas.
Lee SH; Jeong EG; Yoo NJ; Lee SH
APMIS; 2007 Nov; 115(11):1274-80. PubMed ID: 18092960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
